| Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma D Sengupta, A Kannan, M Kern, MA Moreno, E Vural, B Stack Jr, JY Suen, ... Epigenetics 10 (6), 460-466, 2015 | 83 | 2015 |
| BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo Q Shao, A Kannan, Z Lin, BC Stack Jr, JY Suen, L Gao Cancer research 74 (23), 7090-7102, 2014 | 83 | 2014 |
| Chronic mTOR activation promotes cell survival in Merkel cell carcinoma Z Lin, A McDermott, L Shao, A Kannan, M Morgan, BC Stack Jr, M Moreno, ... Cancer letters 344 (2), 272-281, 2014 | 49 | 2014 |
| Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth A Kannan, Z Lin, Q Shao, S Zhao, B Fang, MA Moreno, E Vural, ... Oncotarget 7 (6), 6576, 2016 | 38 | 2016 |
| A proteomic study of human Merkel cell carcinoma Q Shao, SD Byrum, LE Moreland, SG Mackintosh, A Kannan, Z Lin, ... Journal of proteomics & bioinformatics 6, 275, 2013 | 32 | 2013 |
| Transferrin receptor 1-mediated iron uptake regulates bone mass in mice via osteoclast mitochondria and cytoskeleton BK Das, L Wang, T Fujiwara, J Zhou, N Aykin-Burns, KJ Krager, R Lan, ... Elife 11, e73539, 2022 | 29 | 2022 |
| A case of proteasome-associated auto-inflammatory syndrome with compound heterozygous mutations A McDermott, AA Jesus, Y Liu, P Kim, J Jacks, GAM Sanchez, Y Chen, ... Journal of the American Academy of Dermatology 69 (1), e29-e32, 2013 | 23 | 2013 |
| Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts B Fang, A Kannan, S Zhao, QH Nguyen, S Ejadi, M Yamamoto, ... Scientific reports 10 (1), 8867, 2020 | 22 | 2020 |
| A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: Potential impact on CTL epitopes A Srinivasan, V Ayyavoo, S Mahalingam, A Kannan, A Boyd, D Datta, ... Virology journal 5, 1-17, 2008 | 18 | 2008 |
| Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma SJ Park, A Kannan, JP Harris, C Lacy, GA Daniels, SP Lee, N Lambrecht, ... Journal of the American Academy of Dermatology 87 (5), 1209-1211, 2022 | 10 | 2022 |
| Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient J Yeakel, A Kannan, NH Rattigan, M Yamamoto, A Aleshin, JP Harris, ... JAAD Case Reports 18, 94-98, 2021 | 10 | 2021 |
| The cytoplasmic dynein associated protein NDE1 regulates osteoclastogenesis by modulating M-CSF and RANKL signaling pathways BK Das, J Gogoi, A Kannan, L Gao, W Xing, S Mohan, H Zhao Cells 11 (1), 13, 2021 | 8 | 2021 |
| Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis B Fang, A Kannan, T Guo, L Gao International journal of biological sciences 14 (10), 1221, 2018 | 8 | 2018 |
| Selective inhibition of Aurora kinase A by AK-01/LY3295668 attenuates MCC tumor growth by inducing MCC cell cycle arrest and apoptosis BK Das, A Kannan, Q Nguyen, J Gogoi, H Zhao, L Gao Cancers 13 (15), 3708, 2021 | 5 | 2021 |
| Single-cell dissection of Merkel cell carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities BK Das, A Kannan, GJ Velasco, MD Kunika, N Lambrecht, Q Nguyen, ... Cell Reports Medicine 4 (7), 2023 | 4 | 2023 |
| Molecular and functional mapping of Plekhm1-Rab7 interaction in osteoclasts BK Das, T Minocha, MD Kunika, A Kannan, L Gao, S Mohan, W Xing, ... JBMR plus 8 (5), ziae034, 2024 | 1 | 2024 |
| 444 Circulating tumor DNA as a biomarker for treatment response in an advanced Merkel cell carcinoma patient J Yeakel, N Hook, M Yamamoto, A Kannan, E Sanzaro, A Aleshin, ... Journal of Investigative Dermatology 141 (5), S77, 2021 | | 2021 |
| Heat shock enhances innate immune response to PG‐PS and M. tuberculosis in C. elegans K Kannan, X Wan, A Kannan, D Fang, R Ortmann The FASEB Journal 22, 675.21-675.21, 2008 | | 2008 |
